Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07255911
NA

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

Sponsor: Mst.Sumyara Khatun

View on ClinicalTrials.gov

Summary

Does combined Cabergoline and letrozole increase ovulation rate What medical problems do participants have when taking drug Cabergoline and Letrozole ? Researchers will compare drug combination of Cabergoline and letrozole to letrozole alone to see combined cabergoline and letrozole works better as ovulation induction. Participants will: experimental group will receive Cabergoline and Letrozole comparator group will receive letrozole alone TVS Monitoring will be done for 3 cycle for ovarian response

Official title: Cabergoline and Letrozole Compared to Letrozole Alone for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome

Key Details

Gender

FEMALE

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2025-02-07

Completion Date

2026-06-30

Last Updated

2025-12-16

Healthy Volunteers

No

Conditions

Interventions

DRUG

Letrozole 0.5mg

Tab. letrozole 5 mg/day at night from day 2 menstruation/withdrawal bleeding for 5 days for consecutive 3 cycles.

COMBINATION_PRODUCT

Cabergoline 0.5 mg

Tab. cabergoline 0.5 mg 1 tablet at night, two dose at weekly interval (day 2 and day 9 of menstruation/withdrawal bleeding) plus Tab. letrozole 5 mg/day at night from day 2 of menstruation/withdrawal bleeding for 5 days for consecutive 3 cycles.

Locations (1)

Bangladesh Medical University

Dhaka, Shahbag, Bangladesh